Amgen Inc (AMGN)
Total asset turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 25,976,000 | 18,426,000 | 18,462,000 | 18,381,000 | 18,649,000 | 51,099,000 | 51,147,000 | 51,407,000 | 51,365,000 | 25,471,000 | 25,484,000 | 25,164,000 | 25,424,000 | 24,987,000 | 24,301,000 | 23,966,000 | 23,362,000 | 23,395,000 | 23,562,000 | 23,750,000 |
Total assets | US$ in thousands | 97,154,000 | 90,534,000 | 90,269,000 | 88,720,000 | 65,121,000 | 63,700,000 | 59,294,000 | 59,196,000 | 61,165,000 | 64,993,000 | 59,773,000 | 62,539,000 | 62,948,000 | 64,637,000 | 65,011,000 | 61,669,000 | 59,707,000 | 59,535,000 | 59,373,000 | 63,997,000 |
Total asset turnover | 0.27 | 0.20 | 0.20 | 0.21 | 0.29 | 0.80 | 0.86 | 0.87 | 0.84 | 0.39 | 0.43 | 0.40 | 0.40 | 0.39 | 0.37 | 0.39 | 0.39 | 0.39 | 0.40 | 0.37 |
December 31, 2023 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $25,976,000K ÷ $97,154,000K
= 0.27
The total asset turnover ratio for AMGEN Inc. for the past eight quarters has shown a decreasing trend from 0.44 in Q1 2022 to 0.29 in Q4 2023. This ratio indicates that the company is generating $0.29-$0.44 in revenue for every dollar of total assets it holds. The decreasing trend suggests that the company may be becoming less efficient in generating sales from its assets over time. Further analysis is recommended to understand the reasons behind this trend and to identify potential areas for improvement in asset utilization to enhance overall performance.
Peer comparison
Dec 31, 2023
Company name
Symbol
Total asset turnover
Amgen Inc
AMGN
0.27
Bio-Techne Corp
TECH
0.43
Biogen Inc
BIIB
0.37
Gilead Sciences Inc
GILD
0.42
Halozyme Therapeutics Inc
HALO
0.47
Krystal Biotech Inc
KRYS
0.12
Moderna Inc
MRNA
0.37
Neurocrine Biosciences Inc
NBIX
0.58
Regenxbio Inc
RGNX
0.15
Repligen Corporation
RGEN
0.22
Vericel Corp Ord
VCEL
0.56